This article has Open Peer Review reports available.
Identification of fetal cardiac anatomy and hemodynamics: a novel enhanced screening protocol
© The Author(s). 2016
Received: 8 March 2016
Accepted: 14 June 2016
Published: 30 June 2016
Prenatal cardiac screening is of great importance as it contributes to appropriate neonatal management and helps parents to make a decision regarding their pregnancy. The aim of our study was to evaluate the efficiency of a newly proposed screening protocol in the detection of fetal congenital heart disease (CHD).
This was a prospective study. A total of 52 cases of confirmed CHD fetuses and 248 cases of randomly selected normal fetuses were included in the study. Two sonographers with similar experience performed the cardiac screenings under two different protocols independently. The conventional protocol (Protocol A) paid greater attention to the four-chamber view and the outflow tract views. A 6-month training program was provided to sonographers performing scans under the new protocol (Protocol B), which emphasized systematically evaluating fetal cardiac anatomy and hemodynamics. Color Doppler was mandatory and some ultrasonic signs for special cardiac anomalies were also introduced into this protocol.
Protocol B detected more cardiac anomalies than did Protocol A (96.2 % vs. 61.5 %, P < 0.01). Specifically, Protocol B was superior to Protocol A in detecting cardiac malpositions, abnormal systemic and pulmonary venous connection, right aortic arch, transposition of the great arteries, and congenital corrected transposition of the great arteries. By visualizing flow disturbance and retrograde flow with color Doppler, Protocol B was better than Protocol A in screening valvular associated malformations, such as pulmonary atresia, pulmonary stenosis, tricuspid dysplasia, etc. For the normal fetuses, Protocol B was better than Protocol A in reducing the false-positive detection of septal defects.
The current study introduces an enhanced protocol for fetal cardiac screening, under which the obstetric screening sonographers systematically identify fetal cardiac anatomy and hemodynamics. A short-term training program makes it possible for the screening sonographers to become familiar with the new protocol, and its value has been confirmed due to improvements made in screening efficiency.
Congenital heart disease (CHD), accounting for about 0.4–1.3 % of all live births [1–4], is the most common congenital malformation leading to perinatal morbidity and mortality, and is considered the leading cause of death in newborns with congenital anomalies [5, 6]. Fetal echocardiography is undoubtedly the best method currently available to diagnose congenital cardiac anomalies prenatally . However, it is not practical for fetal echocardiographers to make a diagnosis for every fetus during routine obstetric scans. Thus a detailed cardiac screening performed by obstetric sonographers may be an alternative to solving the problem [8–10]. When CHD is suspected, patients should be referred for comprehensive cardiac examination by a fetal echocardiographer. To this end, highly efficient screening might then lead to a high detection rate for fetal CHD.
A symmetric four-chamber view (4CV) has been used to confirm a normal fetal heart since the early 1990s [11, 12]. However, it is well-documented that 4CV alone is inadequate in ruling out conotruncal anomalies [13–15]. The ISUOG guideline  has been revised and updated to include more cardiac views that improve the efficiency of prenatal screening for CHD. In our center, 4CV, combined with double outflow tract views and three-vessel and trachea view (3VT), has been used in routine obstetric screening since 2005. It is confirmed that this produces more effective referrals than ever before. However, we found that there were still many serious CHDs that were missed during screening. We therefore propose an improved screening protocol to enhance current cardiac screening methods.
In total, 253 randomly selected pregnant women who signed their informed consent, and would undergo two screening examinations were included in the current study between Oct 2012 and Oct 2014. As this study was designed to evaluate efficiency of the newly proposed protocol for cardiac screening, we decided to include as many CHD fetuses as possible to strengthen our study, although it was impossible to acquire all the CHD cases during routine obstetric screenings. Pregnant women (a total of 47 cases) whose fetuses had been diagnosed with fetal structural cardiac anomalies in the fetal echocardiography center of our hospital and signed informed consent were also invited to participate in this program between Oct 2012 and Oct 2014.
These patients then underwent thorough screening examinations (including cardiac screening), performed by two obstetric screening sonographers with 2 years of experience independently. Sonographer A performed the scans and made immediate diagnosis under the current screening guidelines (Protocol A). Sonographer B, which was trained for 6 months to become familiar with the proposed protocol (Protocol B), performed the same work under Protocol B.
All fetuses involved in the program were from singleton pregnancies, and the gestational age at scanning ranged from 20 to 24 weeks (mean, 22.4). The screening sonographers involved in the program were not aware of the purpose of the study; and they were also blinded to the patients’ information and prior fetal echocardiographic imaging reports. Three Doppler ultrasound systems (Voluson E8, GE Healthcare, Kretztechnik, Zipf, Austria), each equipped with a 4–8 MHz and a 2–5 MHz transabdominal transducer, were used in our study. All data were saved as video clips. The time for cardiac scans and image interpretation under each protocol was recorded.
Protocol A: transverse sweep from 4CV to 3VT
This protocol was mainly consistent with the one recommended by ISUOG . Briefly, a clear 4CV was acquired with apical or lateral insonation of the fetal heart. The symmetry of the four chambers, atrioventricular coordination, the position where the atrioventricular valves insert into the septum, the separate and free opening of these valves, and the continuity of cardiac crux and interventricular septum were evaluated in 4CV. On the basis of 4CV, the ultrasound beam was gradually turned up to the fetal head to acquire the left and right outflow tract view and the 3VT, through which anomalies associated with conotruncal could be detected. In this protocol, the use of color Doppler was not considered mandatory.
Protocol B: systematic study of fetal cardiac anatomy and hemodynamics, with awareness of some ultrasonic signs of specific anomalies
Sequential segmental analysis was systematically used in this protocol to identify the fetal visceral and cardiac position, and morphologic structures at the atrial, ventricle and arterial levels in an orderly and sequential fashion.
The first step was to determine the fetal visceral and cardiac position, which had been described in detail in our previous report . Briefly, a long-axis plane of the fetus combined with the transverse planes at both the fetal abdominal level and thoracic level were used to ascertain whether both the fetal stomach and heart were on the left side of the fetus.
Some important anatomical structures are meant to be identified, such as pulmonary veins (PV) (at least one left PV and one right PV), superior vena cava (SVC), inferior vena cava (IVC), left/right atrium (LA/RA), left/right ventricle (LV/RV), atrioventricular/semilunar valves, foramen ovale, ovale valve, aorta (ascending aorta and the arch), pulmonary artery (PA) (main PA, bifurcation, and the left and right PA) and the ductus arteriosus (DA).
The connection of the two adjacent segments is to be affirmed clearly; for example, PV connected with LA, LA connected with LV, LV connected with aorta, and the confluence of ductal and aortic arches. To visualize certain anatomical structure, the scans should not be limited to acquiring the transverse view. For example, when 4CV appeared, we rotated the ultrasound beam to the long-axis plane along the RA to confirm that IVC and SVC were connected with RA.
- 3.Color Doppler was very important as it could identify abnormal intracardiac blood flow patterns such as signals across two ventricles, suggesting the existence of a ventricular septal defect (VSD). Color Doppler also made it easier to disclose valvular structural abnormalities compared with 2D sonography (Table 1). In addition, it identified whether the flow direction was correct at certain anatomical locations and determined the existence of abnormalities by analyzing cardiac hemodynamics (Table 1).Table 1
Indications of color Doppler findings in fetal cardiac screening
Abnormal blood flow patterns
Suggest vavular structural anomalies
High velocity blood flow detected at atrioventricular/semilunar valves
Severe TR but with low velocity
Tricuspid valve dysplasia or Ebstein’s anomaly
Non-restrictive pulmonary regurgitation, combined with dilated MPA, LPA, and RPA
Absent pulmonary valve syndrome
Suggest an indirect sign
MR with high velocity
Aortic valve stenosis/atresia
TR with high velocity
Pulmonary valve stenosis/atresia; premature closure of the ductus
Antegrade flow in the DA and retrograde flow in the aorta at 3VT
Aortic valve atresia or COA
Antegrade flow in the aorta and retrograde flow in the DA at 3VT
Pulmonary valve stenosis/atresia
When an abnormal structure is suspected, continuous scans around the anomaly should be performed to determine its source and propose a putative diagnosis.
Abnormal structures that are important for cardiac screening sonographers
Up-abdominal and 4CV level
Associated with cardiac malposition
The heart and the gastric vacuole are both on the right side
Mirror-image heart or complete situs inversus
The heart is on the right side while the gastric vacuole on the left side
Dextrocardia; suggesting a high incidence of CHD
The heart is on the left side while the gastric vacuole on the right side
Heterotaxy; suggesting a high incidence of CHD
4CV shows the displacement of the heart to the right side
Cardiomediastinal shift caused by extra-cardiac situations
Associated with systemic/pulmonary veins connection
A vein flowing cranially was visualized adjacent to the DAO at the 4CV
It may be the azygos or hemizygous continuation of IVC interruption. It is necessary to determine whether IVC is connected with RA
A vein flowing caudally was visualized next to the DAO at the 4CV
It may be TAPVC with an infradiaphragmatic connection. It is necessary to confirm whether PVs is connected with LA.
Vein-like structure was visualized between DAO and LA at the 4CV
It may be pulmonary veins pool. It is necessary to confirm PVs is connected with LA
Coronary sinus was visualized at the atrioventricular groove at the 4CV
It may be caused by the drainage of aberrant PVs or LSVC
A supernumerary Vein-like structure was visualized at the left side of the PA at the 3VT
It may be LSVC
A U-shaped confluence of ductal and aortic arches with the trachea and esophagus located between the two arches
Right-sided aortic arch; suggesting “rings and slings”
Interobserver variability for Protocol A was determined by having another sonographer (Sonographer C) with similar experience re-analyze the imaging data in all the fetuses. For Protocol B, another sonographer (Sonographer D) who had undergone similar training program re-interpreted the imaging data to calculate the interobserver variability. Intraobserver variability for the two protocols were determined by having Sonographer C and D re-interpreted the imaging data in all the fetuses 30 days later under Protocol A and B, respectively. Interobserver and intraobserver variabilities for detecting CHDs were calculated as the absolute differences between the numbers of CHD cases detected by two sonographers as a percent of their mean.
The detection rates for the two protocols were compared via McNemar analysis. P-values < 0.05 were considered statistically significant. All statistical analyses were performed using commercially available software (SPSS, release 17.0).
A total of 300 fetuses were included in the current study. All cases were confirmed by autopsy findings, operative findings, fetal/postnatal echocardiography, or by phone calls in order to acquire the information from routine infant physical examination reports. In our study, patent foramen ovale and patent ductus arteriosus were both considered normal cardiac structures during the follow-up.
Cardiac screening findings in confirmed CHD fetuses and clinical outcomes
Cardiac lesions (n)
Referred for echocardiography (n)
Complete situs inversus (2)
Cardiomediastinal shift (2)
LSVC without RSVC (1)
Interrupted IVC (1)
Large VSD (3)
NND (1); NNA (2)
Small VSD (2)
TOP (1); NNA (1)
Left heart anomalies
IAA and VSD (1)
Right aortic arch (2)
Aortic valve atresia (1)
Right heart anomalies
Ebstein’s anomaly (2)
IUFD (1); NNA (1)
Tricuspid dysplasia (1)
Tricuspid stenosis (1)
Pulmonary atresia (2)
TOP (1); NND (1)
Pulmonary stenosis (1)
Absent pulmonary valve (1)
TOP (1); NND (2)
TOP (1); NNA (2)
TOP (1); NNA (1)
Complex CHDs (3)
NNA(25); NND (7); IUFD (4); TOP (16)
Cardiac screening findings in confirmed normal fetuses
Cardiac screening findings
Referred for further echocardiography (n)
Of all the congenital anomalies, CHD is the most common and has the worst prognosis compared with other disorders due to its high morbidity and mortality [5, 6]. From the early 1990s, fetal echocardiography made it possible to detect CHDs prenatally [11, 12]. Initially, indications for fetal cardiac scans were only based upon some parental risk factors such as maternal diabetes or a positive family history of cardiac anomalies . In the early 2000s, people realized that cardiac examinations should be extended to all fetuses undergoing routine obstetric scans [8, 23–25], and this challenged most obstetric sonographers as fetal cardiac scans and interpretations required a unique set of advanced expertise and knowledge.
Initially, obstetric sonographers recognized that 4CV was easy to visualize during routine scans, and that it was relatively easy to obtain the standard 4CV if the spinal acoustic shadow was avoided. The optimal view of the 4CV is usually obtained when the cardiac apex is directed toward the maternal wall. The introduction of 4CV in routine screenings has proven its value as it could detect some cardiac anomalies at the atrial and ventricular levels, such as large VSD, atrioventricular septal defect (AVSD), Ebstein’s anomaly, hypoplastic left heart syndrome (HLHS), hypoplastic right heart syndrome (HRHS) and space-occupying lesions, etc [9, 26]. In fact, it was relatively easy for us to visualize four asymmetric chambers during prenatal screenings, which provided evidence for further comprehensive examinations. Unfortunately, 4CV alone could not provide the anatomic information at the arterial level, which leads to the low detection rate for conotruncal anomalies [9, 27].
As more concerns have been raised about the low detection rate of 4CV screening, ISUGG revised their previously published guidelines for cardiac screening in mid-gestation. In the new version of the guidelines, transverse scans were recommended to involve both the 4CV and outflow tract views. Also, AIUM has proposed similar guidelines [28, 29]. It is therefore a very important step in improving detection of CHD by complementing the 4CV with the outflow tract views under these guidelines, as documented by several teams and regional studies [13, 15]. Theoretically, most cardiac anomalies can be detected if all the planes could be acquired and the image data interpretations are made correctly. However, our results were not as satisfactory as we had hoped. According to our study, the detection of CHD was only 61.5 % under the protocol using transverse scans. Though this detection rate might be underestimated, as we included more CHD fetuses in our study than in routine screenings, the results implicated the possibility during routine screenings of missed diagnoses for special CHDs. In our experience, we found many CHD neonates manifesting TAPVC, TGA, pulmonary atresia, etc., whose mothers had undergone prenatal screenings at our center but had received no positive fetal diagnosis. Lacking accurate prenatal diagnosis made it impossible to provide appropriate operative schemes and multidisciplinary care. Therefore, many of these neonates died and their families suffered great pain. In fact, as the largest prenatal screening and diagnosis center in northeast China, we have both the best ultrasound equipment and most experienced sonographers. We expect that there are possibly more CHDs misdiagnosed in rural areas, and this is why we decided to propose a new protocol to strengthen the overall efficiency of fetal cardiac screenings.
When the study was completed, we summarized the reasons for the low detection rate under the protocol using transverse scans (Protocol A). An echocardiographer could recognize and diagnose almost all of the CHDs in our study when carefully reviewing the recorded image data acquired from transverse scans. For example, in the case of TAPVC, the tubular-like echo between the descending aorta (DAO) and LA was an important clue to drawing attention to potential cardiac anomalies. However, sonographer under Protocol A did not visualize this abnormal structure because they were not aware that there were no special anatomical structures in the areas between LA and DAO. Also, in the case of left superior vena cava, no vessel-like structures should be detected at the left side of main pulmonary artery (MPA) for normal fetuses. Had the screening sonographers been made aware of this, they would not have made any mistakes. In our proposed new protocol (Protocol B), we solved this problem by introducing into our training program many ultrasonic characters that reflect special cardiac anomalies according to the pathologic anatomy. In fact, Jeanty et al. published a series of reviews [18–21] in which they summarized many of these useful ultrasonic characters for fetal CHDs, and some of these were referenced in our training program in Protocol B (mentioned in the Methods Section). The method proved its value in that the screening sonographers underwent relevant training and could then detect more CHDs than with other techniques.
Our newly proposed protocol emphasized confirming whether the connections of the two adjacent cardiac segments were correct or not. Sequential segmental analysis was recommended to evaluate the fetal cardiac structure and hemodynamcis. Although such analysis is a little difficult for screening sonographers, it justified its value by identifying all the TGA and ccTGA anomalies in the current study. As the 4CV appeared symmetric, these cardiac malformations were easily missed without a careful scan, even if the outflow tract views were scanned during routine screenings. On the contrary, identifying each anatomic structure at each segment, together with confirming the connections between each segment, ensured the successful detection of these complex anomalies.
In addition, the newly proposed protocol emphasized the application of color Doppler during cardiac scans and it justified its value by detecting more cardiac anomalies. For example, in the case of tricuspid dysplasia and tricuspid regurgitation, the thickened valves went undetected in the hands of a screening sonographer using only 2D, although they could be identified by an echocardiography specialist. In fact, color Doppler aids in the detection of flow disturbance, including stenosis and regurgitation, which may not be obvious from interrogation via 2D imaging alone. Furthermore, color Doppler discloses the flow direction in vessels, which is very useful in the detection of cardiac anomalies by assessing cardiac hemodynamics, and Jeanty et al [18–21] reported their experiences in their publications. In our study, we proved this technique’s value in the case of pulmonary atresia in detecting retrograde flow in MPA and DA. As the valvular movement was difficult to observe via 2D, detection of this cardiac abnormality was missed by sonographer under Protocol A, in which color Doppler application was not mandatory.
We must state that there are some limitations to our proposed protocol. First, systematic training was needed to carry out this protocol, which was expensive and time-consuming. However, a 6-month training program has proven to be of great value in improving the efficiency of detecting CHDs during screening. Government investment and funding support may solve this problem. In addition, scans and imaging interpretations under the new protocol, based on sequential segmental analysis, require more time and expertise than under the previous screening protocol. However, we believe that the time commitment might be reduced gradually with the increase in proficiency. In our hands, the time spent scanning and interpreting images was about 15 min for a fetus with normal cardiac structures under the new protocol when the program began, which was then reduced to about 5 to 10 min by the time the study was terminated.
The current study was limited in that it was a relatively small study and did not represent a normal population, i.e., more CHD fetuses were intentionally entered into the study, not reflecting a non-selected population that underwent prenatal screenings. This overall design may bias the results so as to overestimate the difference between the two protocols. We emphasized to summarize the reasons for the cases being missed or detected by the two protocols, as the overall aim of the study was to improve cardiac screening efficiency by proposing a new protocol. As a mono-center based, short-term study, it might be impossible to observe various kinds of CHDs during routine screenings, and the spectrum of CHDs might vary greatly. The current design, then, was intended to include more CHD fetuses to evaluate the ability of the two protocols in screening CHDs, which might compromise the study. However, these limitations, had they been addressed in a multi-center study in a normal screening population, would likely have led to improvements in the completeness of the studies, strengthening our conclusion that the newly proposed protocol was more efficient in detecting CHDs.
The study was also limited in that all fetuses were scanned by only one sonographer under each protocol. The design limited the scanning time for fetal ultrasound examinations under the principle of exposure “as low as reasonably achievable.” Alternatively, we made inter- and intro- variability analysis by having another two sonographers with similar experience to re-analyze the imaging data and made interpretations, respectively. However, this may bias the results as one sonographer only read the videos recorded by the other. If the videos were of poor quality (i.e., a non-standard view, or critical information not presented well), the detection of CHD by the sonographer who did not perform the scan was inevitably low and underestimated.
The current study introduces an enhanced protocol for fetal cardiac screening, under which the obstetric screening sonographers identify the fetal cardiac anatomy and hemodynamics systematically. Some specific ultrasonic signs in certain views help to screen for specific cardiac anomalies. A short-term training program makes it possible for the screening sonographers to become familiar with the new protocol; this has confirmed its value in improving screening efficiency.
2D, two-dimensional; 3VT, three-vessel and trachea view; 4CV, four-chamber view; AVSD, atrioventricular septal defect; ccTGA, congenitally corrected transposition of the great arteries; CHD, congenital heart disease; COA, coarctation of the aorta; DA, ductus arteriosus; DAO, descending aorta; HLHS, hypoplastic left heart syndrome; HRHS, hypoplastic right heart syndrome; IVC, inferior vena cava; LA, left atrium; LV, left ventricle; MPA, main pulmonary artery; PA, pulmonary artery; PAVSD, partial atrioventricular septal defect; PV, pulmonary vein; RA, right atrium; RV, right ventricle; SVC, superior vena cava; TAPVC, total anomalous pulmonary vein connection; TGA, transposition of the great arteries; VSD, ventricular septal defect
We wish to acknowledge Letpub for its linguistic assistance during the preparation of this manuscript.
This work was supported by grant NO. 2012225098 from a scientific research project sponsored by the Science and Technology Agency of Liaoning Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Availability of data and materials
The datasets supporting the conclusions of this article are included within the manuscript (and its additional files). The authors would like to share raw anonymized video data related to the current study, which could only be used for personal study. The demanders may contact email@example.com.
YZ and L-pH designed the whole study. YZ, W-dR, L-pH, D-yZ, and Y-jG drafted the manuscript. YZ, and A-lC performed the fetal echocardiography. YW, WS, LW, YQ performed the cardiac screenings. D-yZ and Y-jG made the data analysis. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
This study was approved by the Ethics Committee of Shengjing Hospital of China Medical University. Written informed consent was obtained from the parents for publication of clinical details, clinical images, and videos.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900.View ArticlePubMedGoogle Scholar
- Massaro AN, El-Dib M, Glass P, Aly H. Factors associated with adverse neurodevelopmental outcomes in infants with congenital heart disease. Brain Dev. 2008;30(7):437–46.View ArticlePubMedGoogle Scholar
- Cuneo BF, Curran LF, Davis N, Elrad H. Trends in prenatal diagnosis of critical cardiac defects in an integrated obstetric and pediatric cardiac imaging center. J Perinatol. 2004;24(11):674–8.View ArticlePubMedGoogle Scholar
- Meberg A, Otterstad JE, Froland G, Lindberg H, Sorland SJ. Outcome of congenital heart defects--a population-based study. Acta Paediatr. 2000;89(11):1344–51.View ArticlePubMedGoogle Scholar
- Gillum RF. Epidemiology of congenital heart disease in the United States. Am Heart J. 1994;127(4 Pt 1):919–27.View ArticlePubMedGoogle Scholar
- Gembruch U. Prenatal diagnosis of congenital heart disease. Prenat Diagn. 1997;17(13):1283–98.View ArticlePubMedGoogle Scholar
- Ayres NA. Advances in fetal echocardiography. Tex Heart Inst J. 1997;24(4):250–9.PubMedPubMed CentralGoogle Scholar
- Hunter S, Heads A, Wyllie J, Robson S. Prenatal diagnosis of congenital heart disease in the northern region of England: benfits of a training programme for obstetric ultrasonographers. Heart. 2000;84(3):294–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Sharland G. Routine fetal cardiac screening: what are we doing and what should we do? Prenat Diagn. 2004;24(13):1123–9.View ArticlePubMedGoogle Scholar
- Chew C, Halliday JL, Riley MM, Penny DJ. Population-based study of antenatal detection of congenital heart disease by ultrasound examination. Ultrasound Obstet Gynecol. 2007;29(6):619–24.View ArticlePubMedGoogle Scholar
- Copel JA, Pilu G, Green J, Hobbins JC, Kleinman CS. Fetal echocardiographic screening for congenital heart disease: the importance of the four-chamber view. Am J Obstet Gynecol. 1987;157(3):648–55.View ArticlePubMedGoogle Scholar
- Allan LD, Crawford DC, Chita SK, Tynan MJ. Prenatal screening for congenital heart disease. Br Med J (Clin Res Ed). 1986;292(6537):1717–9.View ArticleGoogle Scholar
- Oggè G, Gaglioti P, Maccanti S, Faggiano F, Todros T. Prenatal screening for congenital heart disease with four chamber and outflow-tract views: a multicenter study. Ultrasound Obstet Gynecol. 2006;28(6):779–84.View ArticlePubMedGoogle Scholar
- Chaoui R. The four-chamber view: four reasons why it seems to fail in screening for cardiac abnormalities and suggestions to improve detection rate. Ultrasound Obstet Gynecol. 2003;22(1):3–10.View ArticlePubMedGoogle Scholar
- Sklansky MS, Berman DP, Pruetz JD, Chang RK. Prenatal screening for major congenital heart disease: superiority of outflow tracts over the 4-chamber view. J Ultrasound Med. 2009;28(7):889–99.View ArticlePubMedGoogle Scholar
- Carvalho JS, Allan LD, Chaoui R, Copel JA, DeVore GR, Hecher K, Lee W, Munoz H, Paladini D, Tutschek B, Yagel S. ISUOG practice guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol. 2013;41(3):348–59.View ArticlePubMedGoogle Scholar
- Zhang Y, Fan M, Ren WD, Xie LM, Ding CW, Sun W, Wang Y, Guo YJ, Cai AL. Prenatal diagnosis of fetal unilateral lung agenesis complicated with cardiac malposition. BMC Pregnancy Childbirth. 2013;13:79.View ArticlePubMedPubMed CentralGoogle Scholar
- Jeanty P, Chaoui R, Tihonenko I, Grochal F. A review of findings in fetal cardiac section drawings, part 1: The 4-chamber view. J Ultrasound Med. 2007;26(11):1601–10.View ArticlePubMedGoogle Scholar
- Jeanty P, Chaoui R, Grochal F, Tihonenko I. A review of findings in fetal cardiac section drawings, part 2: high abdominal views. J Ultrasound Med. 2007;26(12):1743–6.View ArticlePubMedGoogle Scholar
- Jeanty P, Chaoui R, Tihonenko I, Grochal F. A review of findings in fetal cardiac section drawings, part 3: the 3-vessel-trachea view and variants. J Ultrasound Med. 2008;27(1):109–17.View ArticlePubMedGoogle Scholar
- Jeanty P, Chaoui R, Grochal F. A review of findings in fetal cardiac section drawings, part 4: sagittal and parasagittal views. J Ultrasound Med. 2008;27(6):919–23.View ArticlePubMedGoogle Scholar
- Mapp T. Fetal echocardiography and congenital heart disease. Prof Care Mother Child. 2000;10(1):9–11.PubMedGoogle Scholar
- Ott WJ. The accuracy of antenatal fetal echocardiography screening in high- and low-risk patients. Am J Obstet Gynecol. 1995;172(6):1741–7. discussed 1747-9.View ArticlePubMedGoogle Scholar
- Copel JA, Pilu G, Kleinman CS. Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. Am J Obstet Gynecol. 1986;154(5):1121–32.View ArticlePubMedGoogle Scholar
- Buskens E, Stewart PA, Hess J, Grobbee DE, Wladimiroff W. Efficacy of fetal echocardiography and yield by risk category. Obstet Gynecol. 1996;87(3):423–8.View ArticlePubMedGoogle Scholar
- Sharland GK, Allan LD. Screening for congenital heart disease prenatally. Results of a 2 1/2-year study in the South East Thames Region. Br J Obstet Gynaecol. 1992;99(3):220–5.View ArticlePubMedGoogle Scholar
- Tegnander E, Eik-Nes SH, Johansen OJ, Linker DT. Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a no-selected population. Ultrasound Obstet Gynecol. 1995;5(6):372–80.View ArticlePubMedGoogle Scholar
- American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of fetal echocardiography. J Ultrasound Med. 2011;30(1):127–36.View ArticleGoogle Scholar
- American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of fetal echocardiography. J Ultrasound Med. 2013;32(6):1067–82.View ArticleGoogle Scholar